Learn More
Medchemexpress LLC trans-Pralsetinib | 2097132-93-7 | 533.60 | 1 ML

Supplier: Medchemexpress LLC HY112301A10MM/1ML
trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor, derived from patent US20170121312A1, Compound Example 129.
- Potent rearranged during transfection (RET) inhibitor
- Targets the RET pathway
- Relevant for protein tyrosine kinase/RTK research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.